Trade Ideas

Actionable trade ideas with entry/stop/target and risk framing.

Search Articles
Royal Gold Inc
Jan 5, 2026

Royal Gold: Buy the Streaming Premium as Gold Hits Records

High-margin royalty cash flow, an active M&A pipeline and a rising gold backdrop make RGLD a tactical long - entry 230, stop 210, targets 260/300.

Royal Gold (RGLD) is a royalty and streaming business that is benefiting from a strong gold market and recent deal activity. The company generated $17...

Trade Idea Long
Tenax Therapeutics, Inc.
Jan 5, 2026

Tenax Therapeutics: Lower Phase-3 Variance Has Tilted the Odds — A Long Trade for an Asymmetric Reprice

Clinical noise down, optionality intact — buy a clinical-stage specialty pharma with a clean balance sheet and a lot to gain if levosimendan de-risks.

Tenax (TENX) is a small specialty pharma with North American rights to levosimendan. Recent clinical progress and a materially stronger balance sheet ...

Trade Idea Long
Micron Technology, Inc.
Jan 5, 2026

Micron Upgrade: Memory Supercycle Meets Clean Balance Sheet - Trade the Run

Strong Q1 results, hefty margins, and tightening supply make MU a tactical long - structured entry, stops and targets included.

Micron reported a blowout quarter (Q1 FY2026) with $13.64B revenue and $4.60 diluted EPS, returning to cyclical high margins. Inventory discipline, $8...

Trade Idea Long
Palantir Technologies Inc. Class A Common Stock
Jan 5, 2026

Palantir Is Still Worth Buying — Buy the Dip, Manage the Multiple

Strong quarterly cadence, cash generation, and AI demand justify a tactical long setup — but valuation and contract concentration require tight risk control.

Palantir (PLTR) reported accelerating revenue and profit across the first three quarters of FY2025, is cash-generative, and sits squarely in the enter...

Trade Idea Long
Amazon.Com Inc
Jan 5, 2026

2026 Inflection - Why Amazon’s AWS + AI Mix Could Re-rate the Stock This Year

A position trade: buy into early-2026 momentum as cloud-led margins and ad recovery meet improving free cash flow

Amazon looks poised for a breakout year in 2026. Recent quarterly trends show revenue and operating income acceleration, strong operating cash flow, a...

Trade Idea Long
Axon Enterprise, Inc. Common Stock
Jan 5, 2026

Axon (AXON) - Buy the AI-Driven Moat, Manage the Near-Term Margin Noise

Position trade: AI rollouts and recurring software economics justify a constructive stance; watch tariffs and integration risk.

Axon is executing an AI-forward strategy inside a durable public-safety ecosystem. Recent quarters show strong top-line growth (Q3 FY2025 revenue $710...

Trade Idea Long
Chevron Corporation
Jan 5, 2026

Chevron: Upgrade to Buy on Venezuela Upside — Tactical Long Trade

Strong cash flow, a secure balance sheet, and an outsized geopolitical catalyst make CVX a tactical buy despite elevated event risk.

Chevron (CVX) gets a rating upgrade to Buy as near-term geopolitical developments around Venezuela create asymmetric upside. Fundamentals are solid - ...

Trade Idea Long
Hims & Hers Health, Inc.
Jan 5, 2026

Buy the Dip in Hims & Hers: Back the Subscription Engine While the Street Overreacts

Strong revenue run-rate, positive operating cash flow and a clear membership moat make HIMS a tactical long on weakness.

Hims & Hers (HIMS) just pulled back into the low-$30s after a stretch of outperformance. Fundamentals are intact: mixed but accelerating revenue, posi...

Trade Idea Long
Exxon Mobil Corporation
Jan 5, 2026

Exxon’s Venezuela Pop Is Real-Time News - The Bigger Trade Is The Breakout

Short-term geopolitical lift, longer-term technical breakout with cash-flow and dividend support — actionable swing trade idea on XOM.

Exxon Mobil jumped on January 5, 2026 amid Venezuela-related headlines, but the stock is also clearing structural resistance formed in late 2025. Fund...

Trade Idea Long
Expedia Group, Inc. Common Stock
Jan 5, 2026

Expedia: Strong Quarterly Earnings, Cheap Multiple - Buy the Dip with Defined Risk

Q3 2025 showed outsized profitability; market cap (~$37.4B) implies a sub-10x multiple on run-rate earnings — tactical long.

Expedia reported a $964M net profit in Q3 2025 (diluted EPS $7.33) and operating income of $1.036B, demonstrating that its core OTA businesses still g...

Trade Idea Long
Madrigal Pharmaceuticals, Inc. Common Stock
Jan 5, 2026

Madrigal — Two-Year Rezdiffra Data Narrows Clinical Risk; Buy the Pullback, Trim into Strength

Compelling 2-year MASH cirrhosis signal plus accelerating revenue and >$1.1B cash give a tactical long setup; valuation is rich so size accordingly.

Madrigal (MDGL) is moving from clinical binary risk toward commercialization execution after two-year Rezdiffra data showed benefit in compensated MAS...

Trade Idea Long
Jan 5, 2026

On Holding: Tactical Long — Buy the Market-Share Sprint Underneath the Hype

A swing trade to capture renewed demand and mean-reversion toward last year's highs

On Holding (ONON) is trading around $47.20 as of 01/05/2026. The stock has moved off lows near $35 and remains well below cycle highs near $63. Episod...

Trade Idea Long